PT  - JOURNAL ARTICLE
AU  - Karra, Lakshmi
AU  - Costello, Allison
AU  - Trudeau, Brooke M.
AU  - Khodaee, Morteza
TI  - Are Boosters Necessary If Adult Patients Do Not Achieve Seroconversion After 2 Doses of the MMR Vaccine?
AID  - 10.3122/jabfm.2022.220285R1
DP  - 2023 Feb 08
TA  - The Journal of the American Board of Family
                Medicine
PG  - 142--144
VI  - 36
IP  - 1
4099  - http://www.jabfm.org/content/36/1/142.short
4100  - http://www.jabfm.org/content/36/1/142.full
SO  - J Am Board Fam Med2023 Feb 08; 36
AB  - The Centers for Disease Control (CDC) recommend 2 documented doses of the MMR (measles-mumps-rubella) vaccine for adequate measles, mumps, and rubella immunity for all children and most adults. Sometimes, individuals are asked to provide serologic proof of immunity to measles, mumps, and/or rubella for educational or employment purposes. In other instances, serologic testing may be used to help clarify whether an individual has immunity to measles, mumps, and/or rubella. These serologic tests may sometimes show negative or equivocal antibody titers to measles, mumps and/or rubella, raising the question of adequate immunity. This report provides practical guidance for clinicians on when to use serologic testing to determine measles, mumps, and rubella immunity.